Provides public access to epinephrine auto-injector devices at schools

This bill (A2648) requires all New York schools - including public, charter, and non-public elementary and secondary schools - to maintain and manage epinephrine auto-injector devices for emergency use. Schools must follow specific guidelines: regularly test devices per manufacturer standards, notify regional health councils of device locations, and post clear signage at building entrances indicating where devices are stored. The law designates schools as "public access epinephrine auto-injector device providers" under existing public health law, ensuring devices are accessible during allergic reactions. It takes effect 90 days after enactment, focusing on practical, standardized access without altering medical protocols.